Median Technologies (XPAR:ALMDT) Gross-Profit-to-Asset % : 78.17% (As of Dec. 2023)

View and export this data going back to 2011. Start your Free Trial

What is Median Technologies Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Median Technologies's annualized Gross Profit for the quarter that ended in Dec. 2023 was €22.86 Mil. Median Technologies's average Total Assets over the quarter that ended in Dec. 2023 was €29.25 Mil. Therefore, Median Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 was 78.17%.

Median Technologies Gross-Profit-to-Asset % Historical Data

The historical data trend for Median Technologies's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Median Technologies Gross-Profit-to-Asset % Chart

Median Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Gross-Profit-to-Asset %

Get a 7-Day Free Trial

51.64

64.45

54.72

58.05

65.71

Median Technologies Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Gross-Profit-to-Asset %	Get a 7-Day Free Trial															42.84	54.26	59.89	82.33	78.17

Competitive Comparison of Median Technologies's Gross-Profit-to-Asset %

For the Medical Devices subindustry, Median Technologies's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Median Technologies's Gross-Profit-to-Asset % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Median Technologies's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Median Technologies's Gross-Profit-to-Asset % falls into.

Median Technologies Gross-Profit-to-Asset % Calculation

Median Technologies's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (A: Dec. 2023 )	/	( (Total Assets (A: Dec. 2022 )	+	Total Assets (A: Dec. 2023 ))	/ count )
	=	23.226	/	( (34.753	+	35.935)	/ 2 )
	=	23.226	/	35.344
	=	65.71 %

Median Technologies's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2023 is calculated as:

Gross-Profit-to-Asset %	=	Gross Profit (Q: Dec. 2023 )	/	( (Total Assets (Q: Jun. 2023 )	+	Total Assets (Q: Dec. 2023 ))	/ count )
	=	22.86	/	( (22.556	+	35.935)	/ 2 )
	=	22.86	/	29.2455
	=	78.17 %

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2023) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Median Technologies Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Median Technologies's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Median Technologies (XPAR:ALMDT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Median Technologies (XPAR:ALMDT) » Definitions » Gross-Profit-to-Asset %

Comparable Companies

Traded in Other Exchanges

4ZG:Germany

Address

1800 Route Des Cretes, Les Deux Arcs B, Valbonne, FRA, 06560

Website

https://www.mediantechnologies.com

Median Technologies is engaged in providing medical imaging products and services for diagnosing and monitoring cancer patients in both routine clinical practice and clinical drug development. The firm intends to target the oncology clinical trials market and the cancer patient care market. It developed software-based tools that are integrated into a clinical application portfolio called Lesion Management Solutions. The company has two platforms, iSee for imaging services in clinical trials and iBiopsy for non-invasive diagnostic tests based on imaging for the treatment of patients suffering from cancer and other chronic diseases. Its geographical segments are France, the USA/Canada, the United Kingdom, China, and Other countries.

Median Technologies (XPAR:ALMDT) Headlines

No Headlines